Uncategorized Link to interview with Ms. Anna Gluskin, CEO, Eastgate Biotech Corp. on Wall Street Analyzer March 9, 2022 Posted by admin 09 Mar Anna Gluskin, CEO of Eastgate BioTech (OTC: ETBI) discusses positive results and how they are ready to take the Insulin market by storm.